Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lo

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
Pharmacoepidemiology and Drug Safety|June 5, 2023
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIVJessie Torgersen, Scott Akers, Yuankai Huo, et al.
BMJ Open Respiratory Research|April 9, 2019
Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patientsMichelle E Kho, Alexander J Molloy, France J Clarke, et al.
Annals of Internal Medicine|April 12, 2014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort studyVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Current HIV Research|July 19, 2014
HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ functionKaku A So-Armah, Joyce Chang, Charles Alcorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
AIDS Research and Treatment|March 20, 2015
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designMari M Kitahata, Daniel R Drozd, Heidi M Crane, et al.
Trials|August 29, 2019
Project management lessons learned from the multicentre CYCLE pilot randomized controlled trialDevin S McCaskell, Alexander J Molloy, Laura Childerhose, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studiesVincent Lo Re, Kevin Haynes, Eileen E Ming, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
Pharmacoepidemiology and Drug Safety|June 5, 2023
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIVJessie Torgersen, Scott Akers, Yuankai Huo, et al.
BMJ Open Respiratory Research|April 9, 2019
Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patientsMichelle E Kho, Alexander J Molloy, France J Clarke, et al.
Annals of Internal Medicine|April 12, 2014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort studyVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Current HIV Research|July 19, 2014
HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ functionKaku A So-Armah, Joyce Chang, Charles Alcorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
AIDS Research and Treatment|March 20, 2015
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designMari M Kitahata, Daniel R Drozd, Heidi M Crane, et al.
Trials|August 29, 2019
Project management lessons learned from the multicentre CYCLE pilot randomized controlled trialDevin S McCaskell, Alexander J Molloy, Laura Childerhose, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studiesVincent Lo Re, Kevin Haynes, Eileen E Ming, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Pageof 24